跳至主要内容
临床试验/NCT01987154
NCT01987154已完成不适用

Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula

Mead Johnson Nutrition2 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
61
试验地点
2
主要终点
Enteral intake (ml/kg/day)

研究概览

简要总结

To evaluate the use of a hypoallergenic infant formula containing an extensively hydrolyzed protein source for routine nutrition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
All
接受健康志愿者

入选标准

  • Premature infant 28 to 33 weeks gestational age, inclusive, at birth
  • Infant has never received enteral feedings or current enteral intake is less than 30 mL/kg/day
  • Birth weight is greater than or equal to 700g to 1750g
  • Appropriate birth weight for gestational age
  • Singleton or twin birth
  • Signed Informed consent

排除标准

  • Infant's mother plans to exclusively breast feed
  • 5 minute APGAR score is less than or equal to 4
  • Major surgery that required general anesthesia prior to randomization
  • Ventilator-dependent or requiring greater than 40% FiO2 on day of randomization
  • Grade III or IV intraventricular hemorrhage diagnosed prior to randomization
  • Infant is currently participating in another clinical study

结局指标

主要结局

Enteral intake (ml/kg/day)

时间窗: Daily for 14 days

次要结局

  • Respiratory status(Daily for 14 days)
  • Date of hospital discharge(Once at hospital discharge)
  • Growth(Study Days 1, 7, and 14)
  • Body Weight (g)(Daily for 14 days)
  • Gut Inflammation(Once at Study Day 14)
  • Feeding Tolerance(Daily for 14 days)
  • Confirmed or suspected sepsis or necrotizing enterocolitis(Daily for 14 days)

研究者

发起方
Mead Johnson Nutrition
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验